Back
Tonix Pharmaceuticals Holding Corp. 10K Form
Sell
50
TNXP
Tonix Pharmaceuticals Holding Corp.
Last Price:
$19.52
Seasonality Move:
1.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-13 | 10Q | TNXP/Tonix Pharmaceuticals Holding Corp. Quarterly |
| 2023-11-09 | 10Q | TNXP/Tonix Pharmaceuticals Holding Corp. Quarterly |
| 2023-08-10 | 10Q | TNXP/Tonix Pharmaceuticals Holding Corp. Quarterly |
| 2023-05-08 | 10Q | TNXP/Tonix Pharmaceuticals Holding Corp. Quarterly |
| 2022-11-07 | 10Q | TNXP/Tonix Pharmaceuticals Holding Corp. Quarterly |
| 2022-08-08 | 10Q | TNXP/Tonix Pharmaceuticals Holding Corp. Quarterly |
Receive TNXP News And Ratings
See the #1 stock for the next 7 days that we like better than TNXP
TNXP Financial Statistics
Sales & Book Value
| Annual Sales: | $10.1M |
|---|---|
| Cash Flow: | $-31.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $22.73 |
| Price / Book: | 0.57 |
Profitability
| EPS (TTM): | -986.98720 |
|---|---|
| Net Income (TTM): | $-99.2M |
| Gross Margin: | $-1.1M |
| Return on Equity: | -62.54% |
| Return on Assets: | -55.71% |
Tonix Pharmaceuticals Holding Corp. Earnings Forecast
Key Tonix Pharmaceuticals Holding Corp. Financial Ratios
-
The Gross Profit Margin over the past 18 years for TNXP is -10.82%.
-
The Selling, General & Administrative Expenses for TNXP have been equal to 397.28% of Gross Profit Margin.
-
The Research & Development expenses have been 396.00% of Revenue.
-
The Net Earning history of TNXP is -1,288.25% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 11 years.
Tonix Pharmaceuticals Holding Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TNXP |
| CUSIP: | 890260 |
| Website: | tonixpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.89 |
| Quick Ratio: | 9.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TNXP Technical Analysis vs Fundamental Analysis
Sell
50
Tonix Pharmaceuticals Holding Corp. (TNXP)
is a Sell
Is Tonix Pharmaceuticals Holding Corp. a Buy or a Sell?
-
Tonix Pharmaceuticals Holding Corp. stock is rated a SellThe current Tonix Pharmaceuticals Holding Corp. [TNXP] share price is $17.78. The Score for TNXP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.